• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单细胞空间转录组学揭示了免疫疗法驱动的急性髓系白血病骨髓微环境重塑。

Single-cell spatial transcriptomics reveals immunotherapy-driven bone marrow niche remodeling in AML.

作者信息

Gui Gege, Bingham Molly A, Herzog Julius R, Wong-Rolle Abigail, Dillon Laura W, Goswami Meghali, Martin Eddie, Reeves Jason, Kim Sean, Bahrami Arya, Degenhardt Hermann F, Zaki George, Divakar Prajan, Schrom Edward C, Calvo Katherine R, Hourigan Christopher S, Hansen Kasper D, Zhao Chen

机构信息

Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC, USA.

Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

出版信息

Sci Adv. 2025 Jul 11;11(28):eadw4871. doi: 10.1126/sciadv.adw4871. Epub 2025 Jul 9.

DOI:10.1126/sciadv.adw4871
PMID:40632867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12239967/
Abstract

Given the graft-versus-leukemia effect observed with allogeneic hematopoietic stem cell transplantation in refractory or relapsed acute myeloid leukemia (AML), immunotherapies have been explored in nontransplant settings. We applied a multiomic approach to examine bone marrow interactions in patients with AML treated with pembrolizumab and decitabine. Using extensively trained nuclear and membrane segmentation models, we achieved precise transcript assignment and deep learning-based image analysis. To address read-depth limitations, we integrated single-cell RNA sequencing with single-cell spatial transcriptomics from the same sample. Quantifying cell-cell distances at the edge level enabled more accurate tumor microenvironment analysis, revealing global and local immune cell enrichment near leukemia cells postpembrolizumab treatment, potentially linked to clinical response. Furthermore, ligand-receptor analysis indicated potential alterations in specific signaling pathways between leukemia and immune cells following immunotherapy treatment. These findings provide insights into immune interactions in AML and may inform therapeutic strategies.

摘要

鉴于在难治性或复发性急性髓系白血病(AML)的异基因造血干细胞移植中观察到移植物抗白血病效应,人们已在非移植环境中探索免疫疗法。我们应用了一种多组学方法来研究接受帕博利珠单抗和地西他滨治疗的AML患者的骨髓相互作用。通过使用经过广泛训练的细胞核和细胞膜分割模型,我们实现了精确的转录本分配和基于深度学习的图像分析。为了解决读取深度限制问题,我们将单细胞RNA测序与来自同一样本的单细胞空间转录组学相结合。在边缘水平量化细胞间距离能够进行更准确的肿瘤微环境分析,揭示帕博利珠单抗治疗后白血病细胞附近的全局和局部免疫细胞富集,这可能与临床反应相关。此外,配体-受体分析表明免疫治疗后白血病细胞与免疫细胞之间特定信号通路的潜在改变。这些发现为AML中的免疫相互作用提供了见解,并可能为治疗策略提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a9/12239967/c4513b863216/sciadv.adw4871-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a9/12239967/d8dc8fc2f5f3/sciadv.adw4871-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a9/12239967/cd61c4fbcaef/sciadv.adw4871-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a9/12239967/e471457e0dbc/sciadv.adw4871-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a9/12239967/fe3bf0c87af4/sciadv.adw4871-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a9/12239967/c4513b863216/sciadv.adw4871-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a9/12239967/d8dc8fc2f5f3/sciadv.adw4871-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a9/12239967/cd61c4fbcaef/sciadv.adw4871-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a9/12239967/e471457e0dbc/sciadv.adw4871-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a9/12239967/fe3bf0c87af4/sciadv.adw4871-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a9/12239967/c4513b863216/sciadv.adw4871-f5.jpg

相似文献

1
Single-cell spatial transcriptomics reveals immunotherapy-driven bone marrow niche remodeling in AML.单细胞空间转录组学揭示了免疫疗法驱动的急性髓系白血病骨髓微环境重塑。
Sci Adv. 2025 Jul 11;11(28):eadw4871. doi: 10.1126/sciadv.adw4871. Epub 2025 Jul 9.
2
Single Cell Spatial Transcriptomics Reveals Immunotherapy-Driven Bone Marrow Niche Remodeling in AML.单细胞空间转录组学揭示急性髓系白血病中免疫治疗驱动的骨髓微环境重塑
bioRxiv. 2025 Jan 27:2025.01.24.634753. doi: 10.1101/2025.01.24.634753.
3
REGAL: galinpepimut-S vs. best available therapy as maintenance therapy for acute myeloid leukemia in second remission.REGAL研究:galinpepimut-S与最佳可用疗法作为急性髓系白血病第二次缓解期维持治疗的比较。
Future Oncol. 2025 Jan;21(1):73-81. doi: 10.1080/14796694.2024.2433935. Epub 2024 Nov 28.
4
Mesenchymal stem cells in the bone marrow microenvironment: a double-edged sword for AML.骨髓微环境中的间充质干细胞:急性髓系白血病的双刃剑
J Cancer Res Clin Oncol. 2025 Jun 21;151(6):193. doi: 10.1007/s00432-025-06244-4.
5
Targeting acute myeloid leukemia through antibody engineering: innovations in immunotherapy and combination regimens.通过抗体工程靶向急性髓系白血病:免疫疗法及联合治疗方案的创新
Clin Exp Med. 2025 Jun 24;25(1):215. doi: 10.1007/s10238-025-01764-2.
6
Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33/IL1RL1 pathway.通过阻断IL-33/IL1RL1通路对肿瘤细胞和免疫微环境进行双重靶向作用。
Nat Commun. 2025 Jul 14;16(1):6369. doi: 10.1038/s41467-025-61567-7.
7
Deciphering the tumor immune microenvironment: single-cell and spatial transcriptomic insights into cervical cancer fibroblasts.解析肿瘤免疫微环境:对宫颈癌成纤维细胞的单细胞和空间转录组学见解
J Exp Clin Cancer Res. 2025 Jul 5;44(1):194. doi: 10.1186/s13046-025-03432-5.
8
Potential therapeutic roles of natural killer cells in acute myeloid leukemia: a systematic review study.自然杀伤细胞在急性髓系白血病中的潜在治疗作用:一项系统综述研究
Clin Exp Med. 2025 Jul 4;25(1):233. doi: 10.1007/s10238-025-01786-w.
9
Second allogeneic stem cell transplantation using different donors as the salvage treatment for acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplantation.采用不同供者进行二次异基因干细胞移植作为异基因造血干细胞移植后复发的急性髓系白血病的挽救治疗。
Clin Exp Med. 2025 Jul 15;25(1):249. doi: 10.1007/s10238-025-01787-9.
10
Mechanism of Initial Favorable Response to Decitabine in TP53-Mutated MDS/AML and Potential Mechanisms of Subsequent Relapse.TP53 突变的骨髓增生异常综合征/急性髓系白血病对地西他滨初始良好反应的机制及后续复发的潜在机制
Clin Cancer Res. 2025 Jul 15;31(14):3048-3061. doi: 10.1158/1078-0432.CCR-24-3192.

本文引用的文献

1
Learning representations for image-based profiling of perturbations.基于图像的扰动分析的表示学习。
Nat Commun. 2024 Feb 21;15(1):1594. doi: 10.1038/s41467-024-45999-1.
2
Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapy.与抗PD-1抗体单药治疗疗效相关的单核细胞亚群
Oncol Lett. 2023 Jul 20;26(3):381. doi: 10.3892/ol.2023.13967. eCollection 2023 Sep.
3
Spatial statistics is a comprehensive tool for quantifying cell neighbor relationships and biological processes via tissue image analysis.
空间统计学是一种通过组织图像分析来量化细胞邻居关系和生物过程的综合工具。
Cell Rep Methods. 2022 Nov 21;2(11):100348. doi: 10.1016/j.crmeth.2022.100348.
4
Cellpose 2.0: how to train your own model.Cellpose 2.0:如何训练自己的模型。
Nat Methods. 2022 Dec;19(12):1634-1641. doi: 10.1038/s41592-022-01663-4. Epub 2022 Nov 7.
5
High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging.通过空间分子成像在固定组织中以亚细胞分辨率对RNA和蛋白质进行高多重成像。
Nat Biotechnol. 2022 Dec;40(12):1794-1806. doi: 10.1038/s41587-022-01483-z. Epub 2022 Oct 6.
6
The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution.单细胞分辨率解析原发性黑色素瘤中的进展和免疫编辑的空间景观。
Cancer Discov. 2022 Jun 2;12(6):1518-1541. doi: 10.1158/2159-8290.CD-21-1357.
7
Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma.向浸润性乳腺癌的转变与肿瘤基质的结构和成分的进行性变化有关。
Cell. 2022 Jan 20;185(2):299-310.e18. doi: 10.1016/j.cell.2021.12.023.
8
Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia.派姆单抗联合地西他滨治疗难治性或复发急性髓系白血病。
J Immunother Cancer. 2022 Jan;10(1). doi: 10.1136/jitc-2021-003392.
9
Spatial mapping of protein composition and tissue organization: a primer for multiplexed antibody-based imaging.蛋白质组成和组织架构的空间定位:基于多重抗体成像的入门指南。
Nat Methods. 2022 Mar;19(3):284-295. doi: 10.1038/s41592-021-01316-y. Epub 2021 Nov 22.
10
Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma.免疫细胞图谱预测 PD-1 阻断治疗皮肤 T 细胞淋巴瘤的反应。
Nat Commun. 2021 Nov 18;12(1):6726. doi: 10.1038/s41467-021-26974-6.